Summer Intern, Compound Management
Genesis Therapeutics is pioneering artificial intelligence guided rational drug design to address severe unmet medical needs for patients. Our lab in San Diego is looking for a motivated and enthusiastic team member to join our compound inventory team. You will be responsible for fulfilling compound requests for internal research scientists, adding new compounds to the inventory, and ensuring a proper compound inventory storage environment. In this role you will interact with both chemists and biologists to support all internal drug discovery programs and learn lab/assay workflows that drive the research in a biotech.
What You Will Do:
- Fulfill compound requests in a timely manner.
- Weigh solid samples and create stock solutions.
- Receive and process all compound samples from internal and external sources to be added to the compound inventory, including packaging/unpackaging, labelling, sorting, and proper storage.
- Generate compound plates for testing using laboratory automation such as Hamilton, Echo, and automated pipettes.
- Ensure timelines are met for compound requests and collaborate with other scientists to meet any compound request requirements.
- Maintain and ensure all Compound Management laboratory equipment is in proper working order and properly maintained.
- Additional duties and responsibilities as required.
What You Will Bring:
- Currently enrolled in B.S degree program in related field (biology, chemistry, etc.)
- Good multi-tasking, organizational, record keeping, and communication skills, and the ability to work effectively in an interdisciplinary, team-oriented, collaborative, high performance environment.
- Enthusiasm, integrity, self-motivation, strong interpersonal skills, and attention to detail are necessary.
Genesis Therapeutics is unifying AI and biotech to discover novel and breakthrough treatments for patients with severe and devastating conditions. Genesis was founded on groundbreaking molecular ML research and since has established itself as the industry leader in AI for small molecule drug discovery. Our team of accomplished biotech leaders and expert drug hunters joins forces with deep learning researchers and software engineers who are pioneering predictive and generative AI technologies for molecules.
Our team has created the industry’s most advanced molecular AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and to enable the discovery of novel first-in-class and best-in-class small molecule drugs for challenging and/or undruggable targets.
The company has leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has two AI platform collaborations across a range of therapeutic areas: Eli Lilly (signed in 2022, with a $20M upfront payment and a $670M total deal size), and Genentech (signed in 2020). We raised a $200M series B in August 2023, and have raised over $280M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA’s VC arm), BlackRock, and Menlo Ventures.
Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.
Finding the best talent is our top priority at Genesis Therapeutics. If you are interested in potential partnership on recruitment, please reach out to [email protected]. 
